Abstract
The key intermediate VI was prepared by two ways: by B ring contraction of an androst-5-ene-3β,17α-diol derivative I and by configurational inversion of the 17β-hydroxy group in a B-norandrost-5-ene-3β,17β-diol derivative XII. B-Norepitestosterone (IX) and its potentional metabolite X were then prepared by standard methodology. Both these compounds appear to be inhibitors of 5α-reductase.
Publisher
Institute of Organic Chemistry & Biochemistry
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献